Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)

Catholic Research Network for Multiple Myeloma

doi:10.3324/haematol.2024.285278

Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)

Catholic Research Network for Multiple Myeloma

The Catholic University of Korea Incheon St. Mary's Hospital
The Catholic University of Korea, College of Medicine
Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	4100-4105
Number of pages	6
Journal	Haematologica
Volume	109
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2024.285278
State	Published - Dec 2024

Access to Document

10.3324/haematol.2024.285278

Cite this

@article{60366fc6872443d8b07684375ca938ca,

title = "Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)",

author = "\{Catholic Research Network for Multiple Myeloma\} and Ari Ahn and Park, \{Sung Soo\} and Yonggoo Kim and Lee, \{Jung Yeon\} and Lee, \{Jong Mi\} and Jin Jung and Myungshin Kim and Min, \{Chang Ki\}",

year = "2024",

month = dec,

doi = "10.3324/haematol.2024.285278",

language = "English",

volume = "109",

pages = "4100--4105",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

TY - JOUR

T1 - Minimal residual disease assessment in transplant-eligible patients with multiple myeloma

T2 - real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)

AU - Catholic Research Network for Multiple Myeloma

AU - Ahn, Ari

AU - Park, Sung Soo

AU - Kim, Yonggoo

AU - Lee, Jung Yeon

AU - Lee, Jong Mi

AU - Jung, Jin

AU - Kim, Myungshin

AU - Min, Chang Ki

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85210999099

U2 - 10.3324/haematol.2024.285278

DO - 10.3324/haematol.2024.285278

M3 - Letter

C2 - 39021221

AN - SCOPUS:85210999099

SN - 0390-6078

VL - 109

SP - 4100

EP - 4105

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)

Access to Document

Other files and links

Cite this